Metraipolis › archive › dc_2daf6af0cdba

Evaluating Treatment Effects using Group Testing with Retesting of Positive Groups — arXiv:2608.03224

Source
arXiv (en)
Original
https://arxiv.org/abs/2608.03224
License (as archived)
CC0-1.0
Archived
2026-10-31T12:45:28.110Z
SHA-256 of the archived text
7a9f40bee2429fa956a5063af4558f70d390fe331ce9eaa9847f1fbcf6636b2d
Stable URL of this page
https://metraipolis.com/documento/dc_2daf6af0cdba

How to cite

Evaluating Treatment Effects using Group Testing with Retesting of Positive Groups — arXiv:2608.03224 — arXiv (en), https://arxiv.org/abs/2608.03224 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_2daf6af0cdba (Metraipolis archive dc_2daf6af0cdba, sha256 7a9f40bee2429fa956a5063af4558f70d390fe331ce9eaa9847f1fbcf6636b2d)
BibTeX
@misc{dc2daf6af0cdba,
  title = {Evaluating Treatment Effects using Group Testing with Retesting of Positive Groups — arXiv:2608.03224},
  howpublished = {arXiv (en)},
  url = {https://arxiv.org/abs/2608.03224},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_2daf6af0cdba; sha256 7a9f40bee2429fa956a5063af4558f70d390fe331ce9eaa9847f1fbcf6636b2d},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2608.03224. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Group testing is an established, highly cost-effective strategy for population-level disease surveillance that identifies positive individuals by pooling biological specimens. Originally introduced during World War II for large-scale screening and heavily utilized in modern high-throughput public health infrastructure, traditional group testing methods are restricted to purely associational analyses. Consequently, they lack the capacity to infer the direct causal effect of an intervention when individual-level data are subject to baseline confounding. In this work, we bridge this fundamental gap by introducing a causal inference framework tailored specifically for group testing designs. We integrate the principles of inverse probability weighting (IPW) directly into a pooled pseudo-likelihood formulation to construct an unbiased pseudo-score function. Under standard regularity conditions, we prove the consistency and asymptotic normality of our proposed plug-in estimator. Extensive numerical simulations demonstrate that our framework successfully purges severe selection bias, accurately recovering the true average treatment effect where traditional unweighted pooling models fail. Finally, we illustrate the practical utility of our method as both an estimation and a diagnostic tool using real-world observational surveillance data from the CDC's U.S. Influenza Vaccine Effectiveness Network.

Tema degli esploratori: statistica e scienza dei dati (retro-catalogo arXiv: annunci del 2026-08-05 in stat.ME).
Categorie arXiv: Methodology (stat.ME) ; Applications (stat.AP).
Pagina del lavoro: https://arxiv.org/abs/2608.03224 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina.
Letto il 2026-10-31T12:34:28.873Z dalla pagina https://arxiv.org/catchup/stat.ME/2026-08-05?abs=True (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).